Cite
MLA Citation
Eiichi Tanaka et al.. “Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.” Modern rheumatology, vol. 25, no. 4, 2015, pp. 503–513. http://access.bl.uk/ark:/81055/vdc_100050956010.0x00003b